Living with neurofibromatosis
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llad228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Lisa Murphy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tallaght University Hospital, Tallaght, Dublin, Ireland. Hauptthemen laut MEDLINE: Neurofibromatoses, Neurofibromatosis 1, Neurofibromatosis 2. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Neurofibromatosis type 1 is a genetic disorder that has a number of cutaneous manifestations. Although these lesions typically do not require any form of intervention, it is important for clinicians to be sensitive to the impact that this condition can have on patients’ quality of life regardless. This viewpoint highlights the difficulties encountered by our patient as a result of this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Tallaght University Hospital, Tallaght, Dublin, Ireland.
ORCID-Profile: Lisa Murphy, Claire Doyle
Zitieren
APA
Murphy, L., Andrawis, M., Beatty, P., Costa Blasco, M., Doyle, C., McFeely, O., O'Mahony, S., Wolinska, A., & Connolly, M. (2023). Living with neurofibromatosis. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad228
Vancouver
Murphy L, Andrawis M, Beatty P, Costa Blasco M, Doyle C, McFeely O, et al. Living with neurofibromatosis. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llad228
BibTeX
@article{Murphy2023,
author = {Murphy, Lisa and Andrawis, Madonna and Beatty, Paula and Costa Blasco, Marta and Doyle, Claire and McFeely, Orla and O'Mahony, Sarah and Wolinska, Anna and Connolly, Maureen},
title = {Living with neurofibromatosis},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llad228}
}
EUVIMED